A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL)

被引:0
|
作者
Hahn, Theresa [1 ]
McCarthy, Philip L., Jr. [1 ]
Carreras, Jeanette [2 ]
Zhang, Mei-Jie
Lazarus, Hillard M. [3 ]
Laport, Ginna G. [4 ]
Montoto, Silvia [5 ]
Maloney, David G. [6 ]
Hari, Parameswaran [2 ]
机构
[1] Roswell Pk Canc Inst, Med BMT Program, Buffalo, NY 14263 USA
[2] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA
[3] Univ Hosp Case Med Ctr, Cleveland, OH USA
[4] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
[5] QMUL, Barts Canc Inst, Ctr Haematol Oncol, London, England
[6] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:232 / 233
页数:2
相关论文
共 50 条
  • [1] Simplified Validated Prognostic Model for Progression-Free Survival after Autologous Transplantation for Hodgkin Lymphoma
    Hahn, Theresa
    McCarthy, Philip L.
    Carreras, Jeanette
    Zhang, Mei-Jie
    Lazarus, Hillard M.
    Laport, Ginna G.
    Montoto, Silvia
    Hari, Parameswaran N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (12) : 1740 - 1744
  • [2] Functional Imaging Predicts Progression-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Relapsed/Refractory Hodgkin Lymphoma
    Cho, Christina
    Eaton, Anne
    Barker, Juliet N.
    Castro-Malaspina, Hugo
    Devlin, Sean M.
    Moskowitz, Alison
    Sauter, Craig S.
    Moskowitz, Craig H.
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S218 - S219
  • [3] Comparison of Prognostic Models for Autologous Hematopoietic Stem Cell Transplantation (AHCT) for Relapsed Hodgkin Lymphoma.
    Hahn, Theresa
    McCarthy, Philip L.
    Carreras, Jeanette
    Zhang, Mei-Jie
    Lazarus, Hillard M.
    Laport, Ginna G.
    Montoto, Silvia
    Hari, Parameswaran N.
    BLOOD, 2009, 114 (22) : 499 - 500
  • [4] Risk Factors and a Prognostic Score for Progression Free Survival after Treatment with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory Hodgkin Lymphoma (rrHL)
    Broeckelmann, Paul J.
    Mueller, Horst
    Casasnovas, Olivier
    Hutchings, Martin
    von Tresckow, Bastian
    Borchmann, Peter
    Moskowitz, Craig
    Engert, Andreas
    BLOOD, 2015, 126 (23)
  • [5] Infusion of higher CD34+cell doses in stem cell products is associated with inferior progression-free survival (PFS) after autologous hematopoietic stem cell transplantation (AHSCT) for relapsed and refractory aggressive non-Hodgkin's lymphoma (NHL)
    Robertson, M
    Abonour, R
    Hromas, R
    Nelson, R
    Fineberg, N
    Cornetta, K
    BLOOD, 2003, 102 (11) : 987A - 987A
  • [6] Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma
    Broeckelmann, P. J.
    Mueller, H.
    Casasnovas, O.
    Hutchings, M.
    von Tresckow, B.
    Jurgens, M.
    McCall, S. J.
    Morschhauser, F.
    Fuchs, M.
    Borchmann, P.
    Moskowitz, C. H.
    Engert, A.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1352 - 1358
  • [7] Monocytosis in the Peripheral Blood At First Relapse/Progression Predicts Poorer Overall and Progression-Free Survival After Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma
    Toft-Petersen, Marie
    Kamper, Peter
    Albertsen, Signe
    Secher, Louise
    Segel, Erik Kay
    Clausen, Michael
    d'Amore, Francesco
    BLOOD, 2011, 118 (21) : 677 - 678
  • [8] Correlation of lymphocyte recovery and progression-free survival after autologous stem cell transplantation in patients with Hodgkin's lymphoma
    Mocikova, H.
    Vackova, B.
    Pytlik, R.
    Obrtlikova, P.
    Kobylka, P.
    Trneny, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S216 - S216
  • [9] Prognostic factors, clinical outcome and survival of patients with relapsed or refractory Hodgkin's lymphoma after autologous stem cell transplantation
    Gaudio, F.
    Pastore, D.
    Delia, M.
    Perrone, T.
    Curci, P.
    Laddaga, F. E.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S435 - S435
  • [10] Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
    Driessen, Julia
    Zwezerijnen, Gerben J. C.
    Schoeder, Heiko
    Kersten, Marie Jose
    Moskowitz, Alison J.
    Moskowitz, Craig H.
    Eertink, Jakoba J.
    Heymans, Martijn W.
    Boellaard, Ronald
    Zijlstra, Josee M.
    BLOOD ADVANCES, 2023, 7 (21) : 6732 - 6743